查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947981

单细胞RNA纯化试剂盒市场按应用、最终用户、产品类型、检体来源和试剂盒规格划分，全球预测，2026-2032年

Single Cell RNA Purification Kit Market by Application, End User, Product Type, Sample Source, Kit Format - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，单细胞 RNA 纯化试剂盒市场价值将达到 1.8659 亿美元，到 2026 年将成长至 2.1284 亿美元，到 2032 年将达到 3.9953 亿美元，复合年增长率为 11.49%。

关键市场统计数据
基准年 2025 1.8659亿美元
预计年份：2026年 2.1284亿美元
预测年份 2032 3.9953亿美元
复合年增长率 (%) 11.49%

本书以清晰易懂的方式介绍了单细胞RNA分离技术，并阐述了其性能的可靠性为何决定研究的最终结果。

单细胞RNA纯化技术已成为现代分子生物学和转化研究的基础平台。随着实验通量的提升和单细胞技术从专业研究团队向更广泛的实验室推广，纯化试剂盒的性能、可重复性和易用性日益成为决定实验成败的关键因素。本文重点介绍使纯化试剂盒从普通实用工具昇华为策略资产的技术因素，并着重指出供应商、用户和服务供应商的机会所在。

自动化、化学创新和临床准备如何将单细胞RNA纯化重塑为一个整合的、高性能的工作流程

随着仪器、化学和计算工作流程的进步，单细胞RNA纯化技术领域正经历变革性的转变。自动化和高通量处理的进步，使得人们对试剂盒形式的期望更高，希望其能够实现批次间的一致性，并与机器人液体处理平台无缝整合。同时，磁珠化学和色谱柱结构的创新，使得从传统上难以纯化的样本来源（例如冷冻组织和低起始量血液组分）中也能进行纯化，从而提高了RNA回收率和下游数据品质。

评估2025年美国关税对套件采购中供应链弹性规划与策略采购选择的影响

2025年美国贸易政策趋势为生命科学试剂产业的采购、供应链规划和成本管理带来了新的考量。关税及相关贸易措施影响了供应商的筹资策略，迫使製造商和经销商重新评估生产基地、库存管理政策以及进口组件的合约条款。对于单细胞RNA纯化试剂盒的采购商而言，这些变化使得他们更加重视供应商在原料来源、关税风险以及确保供应连续性的紧急时应对计画的透明度。

综合細項分析揭示了应用需求、最终用户画像、产品类型、样品来源和试剂盒形式如何共同决定采购优先顺序。

细分市场分析能够帮助我们更观点了解单细胞RNA纯化的需求驱动因素和产品需求。依应用领域划分，需求分布如下：癌症研究：生物标记发现和肿瘤微环境分析等子领域需要能够保留脆弱转录本的试剂盒。细胞图谱研究：广泛覆盖和跨多种组织类型的可重复性至关重要。药物发现，包括标靶识别和毒性测试，需要高通量且经济高效的纯化方法。基因表现分析分为mRNA定序流程和总RNA定序工作流程。 mRNA定序工作流程着重于捕捉多聚腺苷酸化转录本，而总RNA定序工作流程则需要与核醣体RNA去除具有高度相容性。

区域研发投资趋势、法规差异和製造地将如何影响纯化试剂盒的全球应用和部署

区域趋势持续影响着单细胞RNA纯化试剂盒的市场应用路径和供应商策略。在美洲，强大的转化研究生态系统和成熟的生物製药总部推动了对支援高通量药物发现和临床检测开发的解决方案的需求，迫使区域製造商和经销商提供快速响应的技术支援和及时的物流服务。政策和采购行为的转变促使研究人员和商业机构优先考虑与那些提供检验的工作流程和本地化库存缓衝的供应商建立合作关係。

顶级供应商为何引领纯化试剂盒市场：结合先进的化学技术、生产规模和全面的技术支持

供应商之间的竞争日益取决于其能否将严谨的化学研发、可扩展的生产製造和强大的技术支援相结合。业界领导企业正投资组成多学科研发团队，以改进微珠化学和色谱柱材料，并检验于包括冷冻组织和低丰度血液组分在内的各种样本类型的通讯协定。此外，他们还与平台供应商合作，确保与下游单细胞工作流程的兼容性，从而增强对寻求整合解决方案的终端用户的价值提案。

为供应商和买家提供切实可行的、优先排序的建议，以增强产品稳健性、供应链弹性和下游工作流程整合。

产业领导者和实验室采购人员应采取一系列切实可行的策略，以掌握当前机会并降低新兴风险。供应商应优先考虑并投资验证产品在不同样本类型（包括週边血单核细胞、全血、贴壁和悬浮细胞培养以及新鲜和冷冻组织）中的稳健性。同时，开发可与现有实验流程整合的自动化优化磁珠配方和基于检验的分离方案，将有助于扩大目标终端用户群。

我们采用透明且可复製的调查方法，结合相关人员访谈、实际技术评估和供应链评估，为我们的策略结论提供支援。

本研究采用定性和定量相结合的三角测量方法，旨在提供可操作且可重复的研究结果。主要资讯来源包括对学术机构、生物製药公司、临床诊断检查室和受託研究机构(CRO) 的实验室主任、采购人员以及研发 (R&D) 科学家进行的结构化访谈。此外，还对技术通讯协定进行了审查，对试剂盒的化学成分和规格进行了实验室间的比较评估，并实地走访了生产和配销中心，以评估供应链实践和品质系统。

简洁扼要的结论强调了创新、供应商可靠性和筹资策略之间的相互作用如何影响其采纳。

单细胞RNA纯化领域处于快速发展的科学与实际实验室限制的交会点。随着单细胞分析技术的不断成熟，纯化试剂盒的相对优势将越来越取决于其对不同样本输入的适应性、与自动化系统的兼容性，以及供应商在不同操作环境下保证可重复性能的能力。因此，策略差异化将源自于化学创新、检验的端到端工作流程以及稳健的生产和分销实践的结合。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：单细胞RNA纯化试剂盒市场（依应用领域划分）

  • 癌症研究
    • 生物标记发现
    • 肿瘤微环境分析
  • 细胞图谱
  • 药物发现
    • 目标识别
    • 毒理学研究
  • 基因表现分析
    • mRNA定序
    • 总RNA定序

9. 依最终用户分類的单细胞RNA纯化试剂盒市场

  • 学术研究
    • 政府机构
    • 大学研究所
  • 生物製药公司
    • 大型製药企业
    • 中小型製药公司
  • 临床诊断检查室
    • 分子诊断实验室
    • 病理检查室
  • CRO（受託研究机构）
    • 临床研究
    • 临床前研究

第十章：单细胞RNA纯化试剂盒市场（依产品类型划分）

  • 基于列
    • 旋转柱
    • 真空柱
  • 以微珠为基础的
    • 聚苯乙烯珠
    • 二氧化硅包覆珠

第十一章：依检体来源分類的单细胞RNA纯化试剂盒市场

  • 血
    • 週边血单核细胞
    • 全血
  • 细胞培养
    • 贴壁细胞
    • 悬浮细胞
  • 组织
    • 新鲜纸巾
    • 冷冻组织

第十二章：单细胞RNA纯化试剂盒市场（依试剂盒规格划分）

  • 散装
  • 免洗套装

第十三章：单细胞RNA纯化试剂盒市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 单细胞RNA纯化试剂盒市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 单细胞RNA纯化试剂盒市场（依国家划分）

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国：单细胞RNA纯化试剂盒市场

17. 中国单细胞RNA纯化试剂盒市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company（BD）
  • Bio-Rad Laboratories, Inc.
  • Cytena GmbH
  • Dolomite Bio
  • Fluxion Biosciences, Inc.
  • Illumina, Inc.
  • MGI Tech Co. Ltd.
  • Miltenyi Biotec BV & Co. KG
  • Mission Bio, Inc.
  • NanoString Technologies, Inc.
  • New England Biolabs, Inc.
  • Parse Biosciences, Inc.
  • QIAGEN NV
  • Singleron Biotechnologies GmbH
  • Sphere Fluidics Limited
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4F7A6D4FB6C0

The Single Cell RNA Purification Kit Market was valued at USD 186.59 million in 2025 and is projected to grow to USD 212.84 million in 2026, with a CAGR of 11.49%, reaching USD 399.53 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 186.59 million
Estimated Year [2026] USD 212.84 million
Forecast Year [2032] USD 399.53 million
CAGR (%) 11.49%

A clear and compelling introduction to single-cell RNA purification technologies and why performance fidelity now determines research outcomes

Single-cell RNA purification has become a foundational enabling technology for contemporary molecular biology and translational research. As experimental throughput scales and single-cell methods migrate from specialist groups to broader laboratory adoption, the performance, reproducibility, and ease of integration of purification kits are increasingly determinative of experimental success. This introduction frames the opportunity set for suppliers, users, and service providers by clarifying the technical drivers that elevate a purification kit from utility to strategic asset.

Across both discovery and applied domains, researchers prioritize sample integrity, RNA yield, and compatibility with downstream workflows such as mRNA sequencing and total RNA sequencing. The expanding toolkit of single-cell analytics, including droplet-based platforms and microfluidic systems, places new demands on purification chemistries and formats. Consequently, stakeholders must evaluate kits not only by immediate performance metrics but also by adaptability to diverse sample sources, throughput requirements, and regulatory constraints, which together define long-term utility and procurement strategy.

How automation, chemistry innovation, and clinical-readiness are reshaping single-cell RNA purification into integrated high-performance workflows

The landscape of single-cell RNA purification is undergoing transformative shifts driven by converging advances in instrumentation, chemistry, and computational workflows. Automation and high-throughput processing have elevated expectations around kit formats that support batch consistency and seamless integration with robotic liquid-handling platforms. In parallel, innovations in magnetic bead chemistries and column architectures are enabling purifications from increasingly challenging sample sources such as frozen tissue and low-input blood fractions, improving both recovery and downstream data quality.

Another inflection is the blurring of boundaries between discovery and clinical contexts. As workflows mature and standardization improves, purification kits once confined to academic research are being evaluated by clinical diagnostics laboratories for reproducibility and regulatory readiness. This has prompted suppliers to invest in validated protocols, improved documentation, and formats that accommodate single-use clinical workflows as well as bulk packs for high-throughput labs. Additionally, the rise of integrated solutions-where kits are co-optimized with library-prep and sequencing chemistries-has created new value propositions centered on end-to-end performance rather than isolated component metrics. These shifts are accelerating adoption among a wider set of end users while simultaneously raising the bar for product differentiation and supplier reliability.

Assessing how 2025 United States tariff actions are prompting supply-chain resilience planning and strategic sourcing choices for kit procurement

Trade policy developments in the United States in 2025 have introduced new considerations for procurement, supply-chain planning, and cost management across the life-science reagent landscape. Tariffs and related trade measures have influenced supplier sourcing strategies, prompting manufacturers and distributors to reassess production footprints, inventory policies, and contractual terms for imported components. For purchasers of single-cell RNA purification kits, these dynamics have translated into greater emphasis on supplier transparency regarding origin of raw materials, tariff exposure, and contingency plans to ensure continuity of supply.

In response to tariff-driven uncertainty, many stakeholders have accelerated supplier qualification processes and expanded their supplier base to include domestic and regionally located vendors. This pivot is reflected in increased interest in product formats that reduce dependency on imported consumables, such as magnetic bead formulations that can be sourced from diversified chemical suppliers or column designs that leverage locally manufactured plastics. Consequently, procurement teams now evaluate not only technical compatibility but also supply-chain resilience, lead-time variability, and the vendor's ability to navigate customs and regulatory compliance. Strategic buyers are instituting multi-tier sourcing strategies, contractual clauses for tariff pass-through, and collaborative forecasting with preferred suppliers to mitigate the operational disruption caused by trade-policy shifts.

Integrated segmentation analysis revealing how application needs, end-user profiles, product types, sample sources, and kit formats jointly determine procurement priorities

Segmentation provides a nuanced lens for understanding demand drivers and product requirements in single-cell RNA purification. Based on application, demand is distributed across cancer research where subfields such as biomarker discovery and tumor microenvironment profiling require kits capable of preserving fragile transcripts; cell atlas initiatives where breadth and reproducibility across diverse tissue types are paramount; drug discovery domains that include target identification and toxicology studies which demand high-throughput, cost-effective formats; and gene expression analysis which bifurcates into mRNA sequencing workflows favoring polyadenylated transcript capture and total RNA sequencing workflows requiring robust ribosomal RNA depletion compatibility.

When viewed from the end-user perspective, academic research laboratories-including both government institutes and university facilities-prioritize flexibility and protocol transparency, while biopharmaceutical companies, spanning large and small pharmaceutical developers, emphasize validated lot-to-lot consistency and scale. Clinical diagnostics laboratories, from molecular diagnostics providers to pathology labs, require regulatory-grade documentation and single-use formats tailored for clinical workflows. Contract research organizations active in clinical and preclinical research demand reproducible performance across diverse sample types and the logistical efficiency to support multi-site studies. Product-type segmentation distinguishes column-based solutions-offering spin column and vacuum column variants that appeal to established bench workflows-from magnetic bead-based options, where polystyrene beads and silica-coated bead chemistries offer advantages in automation and low-input recovery. Sample-source segmentation underscores the technical diversity inherent in processing peripheral blood mononuclear cells and whole blood versus adherent or suspension cell cultures, and fresh versus frozen tissue, each of which imposes unique extraction constraints. Finally, kit-format considerations separate bulk packs, available in larger quantity configurations such as fifty packs and ten packs useful for high-throughput settings, from single-use kits that serve low-volume and standard-volume needs for regulated or contamination-sensitive environments.

Taken together, these segmentation axes illuminate where suppliers should focus product development and commercialization efforts. Application- and end-user-driven requirements create cross-cutting demands for reproducibility, documentation, and format flexibility, while product-type and sample-source distinctions inform the chemistry and engineering choices that define competitive differentiation.

How regional research investment trends, regulatory diversity, and manufacturing footprints are shaping the adoption and deployment of purification kits globally

Regional dynamics continue to shape adoption pathways and supplier strategies for single-cell RNA purification kits. In the Americas, strong translational research ecosystems and established biopharmaceutical headquarters drive demand for solutions that support high-throughput drug discovery and clinical assay development, and regional manufacturers and distributors are under pressure to provide rapid technical support and just-in-time logistics. Shifts in policy and procurement behavior have encouraged both researchers and commercial entities to prioritize supplier relationships that offer validated workflows and localized inventory buffering.

In Europe, the Middle East and Africa, heterogeneous regulatory frameworks and public research funding models create a mosaic of procurement behaviors, where clinical laboratories seek compliance-ready products and academic consortia emphasize interoperability and open protocols. This region shows pronounced interest in modular kit formats that can be adapted across diverse tissue types and sample-preparation pipelines. The Asia-Pacific region is characterized by rapid capacity growth in research infrastructure, expanding clinical diagnostics capabilities, and a growing base of domestic manufacturers; investors and purchasers here prioritize scalable kit formats, regional manufacturing partnerships, and supplier roadmaps that accommodate rapid technology transfer and local regulatory submission needs. Across all regions, cross-border logistics resilience and the ability to provide regionally tailored technical training and documentation are differentiators that accelerate adoption.

Why top-performing suppliers combine advanced chemistry, manufacturing scale, and comprehensive technical support to lead in the purification kit market

Competitive dynamics among suppliers are increasingly defined by the ability to combine rigorous chemistry development with scalable manufacturing and strong technical support. Industry leaders are investing in cross-disciplinary R&D teams to refine bead chemistries and column materials, and to validate protocols across a broader array of sample types including frozen tissue and low-abundance blood fractions. These investments are complemented by partnerships with platform providers to ensure compatibility with downstream single-cell workflows, which strengthens value propositions for end users seeking integrated solutions.

Beyond product performance, companies that excel are those that demonstrate supply-chain transparency, robust quality systems, and comprehensive training resources. Strategic moves such as expanding regional manufacturing, introducing single-use kit formats for regulated environments, and offering validated workflows for both mRNA and total RNA sequencing are shaping buyer preferences. Additionally, some suppliers are differentiating through service offerings-providing protocol validation, on-site training, or application support-which lowers the barrier to adoption for clinical and contract research organizations. Overall, success is accruing to firms that align technical excellence with logistical reliability and a clear commitment to customer enablement.

Practical and prioritized recommendations for suppliers and buyers to enhance product robustness, supply resilience, and downstream workflow integration

Industry leaders and laboratory buyers should adopt a set of actionable strategies to capitalize on current opportunities and mitigate emerging risks. Suppliers must prioritize product robustness across a spectrum of sample types, investing in validation for peripheral blood mononuclear cells, whole blood, adherent and suspension cell cultures, and both fresh and frozen tissues. Concurrently, developing magnetic bead formulations optimized for automation as well as column-based options that integrate with established bench workflows will broaden addressable end-user segments.

Procurement teams should implement supplier qualification processes that explicitly evaluate origin of components, tariff exposure, and contingency logistics to limit operational disruption. Suppliers and buyers alike will benefit from collaborative pilot projects that co-validate kits with downstream library-prep and sequencing workflows, thereby reducing adoption friction for biopharmaceutical and clinical diagnostic customers. Finally, firms should invest in modular kit formats and documentation packages that respond to the diverse needs of academic research, large and small pharmaceutical companies, clinical diagnostics laboratories, and contract research organizations, enabling both rapid adoption and long-term retention.

Transparent and reproducible research methodology combining stakeholder interviews, hands-on technical evaluations, and supply-chain assessments to underpin strategic conclusions

This research draws on a triangulation of qualitative and quantitative methods designed to deliver actionable, reproducible insights. Primary sources include structured interviews with laboratory directors, procurement managers, and R&D scientists across academic institutions, biopharmaceutical companies, clinical diagnostics laboratories, and contract research organizations. These interviews were complemented by technical protocol reviews, comparative laboratory evaluations of kit chemistries and formats, and site visits to manufacturing and distribution centers to assess supply-chain practices and quality systems.

Secondary research incorporated peer-reviewed literature on single-cell methodologies, regulatory guidance for clinical assay components, and public disclosures regarding supplier investments in manufacturing capacity and automation. Data synthesis relied on cross-validation across sources to identify consistent trends and to filter short-term noise from persistent strategic shifts. Throughout the research process, attention was given to methodological transparency, reproducibility of laboratory findings, and the contextualization of tariff and policy developments within operational procurement practices.

A concise conclusion emphasizing the interplay of technical innovation, supplier reliability, and procurement strategy in shaping adoption

The single-cell RNA purification domain sits at the intersection of rapidly evolving science and practical laboratory constraints. As technologies for single-cell analysis continue to mature, the relative advantage of purification kits will increasingly depend on their adaptability to diverse sample inputs, their compatibility with automation, and the supplier's ability to ensure reproducible performance across operational contexts. Strategic differentiation will therefore emerge from a combination of chemical innovation, validated end-to-end workflows, and resilient manufacturing and distribution practices.

For decision-makers, the imperative is to align procurement choices with long-term experimental objectives and regulatory trajectories. Suppliers that deliver documented reproducibility, comprehensive technical support, and flexible kit formats will capture the attention of both discovery-oriented and clinical customers. In the near term, organizations that emphasize supplier vetting, collaborative validation efforts, and contingency planning will be best positioned to maintain research continuity and to capitalize on the growing opportunities presented by single-cell biology.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Single Cell RNA Purification Kit Market, by Application

  • 8.1. Cancer Research
    • 8.1.1. Biomarker Discovery
    • 8.1.2. Tumor Microenvironment Profiling
  • 8.2. Cell Atlas
  • 8.3. Drug Discovery
    • 8.3.1. Target Identification
    • 8.3.2. Toxicology Studies
  • 8.4. Gene Expression Analysis
    • 8.4.1. Mrna Sequencing
    • 8.4.2. Total Rna Sequencing

9. Single Cell RNA Purification Kit Market, by End User

  • 9.1. Academic Research
    • 9.1.1. Government Institutes
    • 9.1.2. University Laboratories
  • 9.2. Biopharmaceutical Companies
    • 9.2.1. Large Pharmaceuticals
    • 9.2.2. Small Pharmaceuticals
  • 9.3. Clinical Diagnostics Laboratories
    • 9.3.1. Molecular Diagnostics Laboratories
    • 9.3.2. Pathology Laboratories
  • 9.4. Contract Research Organizations
    • 9.4.1. Clinical Research
    • 9.4.2. Preclinical Research

10. Single Cell RNA Purification Kit Market, by Product Type

  • 10.1. Column Based
    • 10.1.1. Spin Column
    • 10.1.2. Vacuum Column
  • 10.2. Magnetic Bead Based
    • 10.2.1. Polystyrene Beads
    • 10.2.2. Silica Coated Beads

11. Single Cell RNA Purification Kit Market, by Sample Source

  • 11.1. Blood
    • 11.1.1. Peripheral Blood Mononuclear Cells
    • 11.1.2. Whole Blood
  • 11.2. Cell Culture
    • 11.2.1. Adherent Cells
    • 11.2.2. Suspension Cells
  • 11.3. Tissue
    • 11.3.1. Fresh Tissue
    • 11.3.2. Frozen Tissue

12. Single Cell RNA Purification Kit Market, by Kit Format

  • 12.1. Bulk Packs
  • 12.2. Single Use Kits

13. Single Cell RNA Purification Kit Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Single Cell RNA Purification Kit Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Single Cell RNA Purification Kit Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Single Cell RNA Purification Kit Market

17. China Single Cell RNA Purification Kit Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 10x Genomics, Inc.
  • 18.6. Agilent Technologies, Inc.
  • 18.7. Becton, Dickinson and Company (BD)
  • 18.8. Bio-Rad Laboratories, Inc.
  • 18.9. Cytena GmbH
  • 18.10. Dolomite Bio
  • 18.11. Fluxion Biosciences, Inc.
  • 18.12. Illumina, Inc.
  • 18.13. MGI Tech Co. Ltd.
  • 18.14. Miltenyi Biotec B.V. & Co. KG
  • 18.15. Mission Bio, Inc.
  • 18.16. NanoString Technologies, Inc.
  • 18.17. New England Biolabs, Inc.
  • 18.18. Parse Biosciences, Inc.
  • 18.19. QIAGEN N.V.
  • 18.20. Singleron Biotechnologies GmbH
  • 18.21. Sphere Fluidics Limited
  • 18.22. Takara Bio Inc.
  • 18.23. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TUMOR MICROENVIRONMENT PROFILING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TUMOR MICROENVIRONMENT PROFILING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TUMOR MICROENVIRONMENT PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL ATLAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL ATLAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL ATLAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOXICOLOGY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOXICOLOGY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MRNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MRNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MRNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOTAL RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOTAL RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOTAL RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GOVERNMENT INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY UNIVERSITY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY UNIVERSITY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY LARGE PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY LARGE PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY LARGE PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SMALL PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SMALL PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SMALL PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PATHOLOGY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PATHOLOGY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SPIN COLUMN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SPIN COLUMN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SPIN COLUMN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY VACUUM COLUMN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY VACUUM COLUMN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY VACUUM COLUMN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY POLYSTYRENE BEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY POLYSTYRENE BEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY POLYSTYRENE BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SILICA COATED BEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SILICA COATED BEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SILICA COATED BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PERIPHERAL BLOOD MONONUCLEAR CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PERIPHERAL BLOOD MONONUCLEAR CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PERIPHERAL BLOOD MONONUCLEAR CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ADHERENT CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ADHERENT CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ADHERENT CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SUSPENSION CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SUSPENSION CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SUSPENSION CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FRESH TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FRESH TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FRESH TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FROZEN TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FROZEN TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FROZEN TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BULK PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BULK PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BULK PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SINGLE USE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SINGLE USE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SINGLE USE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 281. GLOBAL SINGLE CELL RNA PURIFI